BBNX vs XLI
Beta Bionics, Inc. Common Stock (BBNX) versus XLI (XLI) — a side-by-side from cached financials, not a winner call.
Beta Bionics, Inc. Common Stock (BBNX) is a medical devices company listed on NASDAQ.
XLI (XLI) common stock.
Latest reported BBNX revenue for 2025-12-31 was $100.3M. Net income was -$73.2M. Revenue was up 53.9% from 2024-12-31 to 2025-12-31. BBNX currently screens at market cap $640.8M.
XLI does not have a complete income-statement cache yet.
BBNX currently screens at market cap $640.8M. XLI currently screens at market cap $0.
Not investment advice. Open the BBNX and XLI stock pages for the full models.
Not investment advice.